Antithrombin III in Infectious Disease Caused by COVID-19

Clinical trial NCT04899232 · TERMINATED

Trial details

NCT number: NCT04899232
Sponsor: Enrique Ginzburg
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Antithrombin III Deficiency Covid19

Start date: 2021-07-06
Primary completion: 2022-03-31
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.